SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-001432
Filing Date
2016-05-20
Accepted
2016-05-19 21:54:53
Documents
4
Period of Report
2016-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 31512
2 EXHIBIT 99.1 - PRESS RELEASE ex99_1.htm EX-99.1 12052
3 logo.jpg GRAPHIC 8056
4 sm-logo.jpg GRAPHIC 3101
  Complete submission text file 0001341004-16-001432.txt   60468
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161664602
SIC: 2834 Pharmaceutical Preparations